.Novo Nordisk is actually proceeding its push into hereditary medicines, agreeing to pay NanoVation ...
.Innovent Biologics has made the case that its checkpoint inhibitor-cytokine blend protein possesses...
.A period 3 trial of Daiichi Sankyo as well as Merck & Co.'s HER3-directed antibody-drug conjugat...
.Five months after Rakovina Rehabs rotated toward artificial intelligence, the cancer-focused biotec...
.Ascendis Pharma has become a prospective hazard to BioMarin's Voxzogo, disclosing phase 3 growth pr...
.Though Alkeus Pharmaceuticals' oral eye ailment possession neglected to significantly lessen geogra...
.Along with a triad of biotechs hitting the Nasdaq on Friday, it was quick and easy to miss out on a...
.Invulnerable gate preventions are the superheroes of cancer treatment. Medicines like Bristol Myers...
.Invite to recently's Chutes & Ladders, our summary of significant management hirings, firings an...
.Regeneron is actually back with long-lasting follow-up for its own LAG-3 prevention as well as PD-1...